Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Amman, Jordan Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting. Riad Mishlawi, Hikma’s CEO, said: “Hikma has had a strong start to 2024, with continued growth and momentum across the Group. Our three businesses are performingContinue Reading

Free Pops for All the Gals on Women’s Day

Dubai, United Arab Emirates Marking International Women’s Day 2024 – March 8th – all women are invited to take advantage of a free frozen treat, courtesy of everyone’s favourite treat brand, House of Pops. Head to the iconic brand’s brightly coloured venues on Kite Beach, Jumeirah, or beside the Dubai Eye on BluewatersContinue Reading

Al Dhaheri Jones & Clark (ADJC) confirms the application of a 5% Value Added Tax (VAT) on all purchases made through online shopping portals

ADJC remains steadfast in helping businesses comply with tax laws seamlessly Dubai, UAE, 14 September 2023: Al Dhaheri Jones & Clark (ADJC) stated that The Federal Tax Authority (FTA) has confirmed the application of a 5% Value Added Tax (VAT) on all purchases made through online shopping portals in theContinue Reading

Hikma delivers strong H1 performance and raises Generics guidance Growth in all three businesses and across all geographies

Hikma Pharmaceuticals PLC and its subsidiaries (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, report its interim results for the six months ended 30 June 2023. During the first half of 2023, core group revenue grew 18% to $1.427 billion (compared to H1 2022: $1.213 billion), driven by a strong performanceContinue Reading